Higher serum levels of rheumatoid factor and anti-nuclear antibodies in helicobacter pylori-infected peptic ulcer patients
- PMID: 23904920
- PMCID: PMC3725249
- DOI: 10.5001/omj.2013.74
Higher serum levels of rheumatoid factor and anti-nuclear antibodies in helicobacter pylori-infected peptic ulcer patients
Abstract
Objectives: H. pylori infection has been associated with some autoimmune disorders. The aim of this study was to evaluate the serum concentrations of rheumatoid factor and anti-nuclear antibodies in H. pylori-infected peptic ulcer patients, H. pylori-infected asymptomatic carriers and a healthy control group.
Methods: A Total of 100 H. pylori-infected peptic ulcer patients, 65 asymptomatic carriers and 30 healthy H. pylori-negative subjects (as a control group) were enrolled into study. Serum samples of participants tested for the levels of rheumatoid factor and anti-nuclear antibodies by use of ELISA.
Results: The mean serum levels of rheumatoid factor and anti-nuclear antibodies in peptic ulcer group was significantly higher in comparison to the control group (p<0.05). Although, the mean serum levels of rheumatoid factor and anti-nuclear antibodies in the asymptomatic carriers group was higher than those in the control group, the difference was not statistically significant. No significant differences were observed between peptic ulcer patients and asymptomatic carriers groups regarding the mean serum levels of rheumatoid factor and anti-nuclear antibodies. The mean serum levels of rheumatoid factor in men with peptic ulcer was significantly higher compared to the group of healthy men (p<0.05). Although in female of peptic ulcer patients or asymptomatic carriers groups, the mean serum levels of rheumatoid factor was higher than that in healthy women, but the differences were not statistically significant. Also, no significant differences were observed between men and women with peptic ulcer, asymptomatic carriers control groups based on the serum levels of anti-nuclear antibodies.
Conclusion: The results showed higher serum levels of rheumatoid factor and anti-nuclear antibodies in H. pylori-infected patients with peptic ulcer disease which represent the H. pylori-related immune disturbance in these patients. Additional follow-up studies are necessary to clarify the clinical significance of these autoantibodies in patients with H. pylori infection.
Keywords: Anti-nuclear antibody; Helicobacter pylori; Peptic ulcer; Rheumatoid factor.
Similar articles
-
Higher circulating levels of anti-phosphatidylserine antibody in peptic ulcer patients infected with CagA-positive strains of Helicobacter pylori.Clin Lab. 2013;59(9-10):977-84. doi: 10.7754/clin.lab.2012.120719. Clin Lab. 2013. PMID: 24273919
-
Serum levels of high-sensitivity C-reactive protein (hs-CRP)in Helicobacter pylori-infected peptic ulcer patients and its association with bacterial CagA virulence factor.Dig Dis Sci. 2009 Dec;54(12):2612-6. doi: 10.1007/s10620-008-0686-z. Dig Dis Sci. 2009. PMID: 19160050
-
Serum CagA antibodies in asymptomatic subjects and patients with peptic ulcer: lack of correlation of IgG antibody in patients with peptic ulcer or asymptomatic Helicobacter pylori gastritis.J Clin Pathol. 1996 Oct;49(10):829-32. doi: 10.1136/jcp.49.10.829. J Clin Pathol. 1996. PMID: 8943750 Free PMC article.
-
Helicobacter pylori-associated peptic ulcer disease in older patients: current management strategies.Drugs Aging. 2001;18(7):487-94. doi: 10.2165/00002512-200118070-00002. Drugs Aging. 2001. PMID: 11482742 Review.
-
Helicobacter pylori and peptic ulcer disease.Scand J Gastroenterol Suppl. 1996;214:24-7; discussion 42-3. Scand J Gastroenterol Suppl. 1996. PMID: 8722401 Review.
Cited by
-
Immunological tolerance as a barrier to protective HIV humoral immunity.Curr Opin Immunol. 2017 Aug;47:26-34. doi: 10.1016/j.coi.2017.06.004. Epub 2017 Jul 17. Curr Opin Immunol. 2017. PMID: 28728075 Free PMC article. Review.
-
Risk of Moderate to Severe Ocular Surface Disease Associated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy: A Multicenter Cohort Study.Ophthalmol Ther. 2025 Sep;14(9):2179-2196. doi: 10.1007/s40123-025-01200-4. Epub 2025 Jul 17. Ophthalmol Ther. 2025. PMID: 40676408
-
SARS-CoV-2 infection relaxes peripheral B cell tolerance.J Exp Med. 2022 Jun 6;219(6):e20212553. doi: 10.1084/jem.20212553. Epub 2022 Apr 14. J Exp Med. 2022. PMID: 35420627 Free PMC article.
References
-
- Ohta M. [Helicobacter pylori infection and autoimmune disease such as immune thrombocytopenic purpura]. Kansenshogaku Zasshi 2010. Jan;84(1):1-8 - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources